Switch to
More onapp

Arvee Laboratories (India) Ltd

ARVEE
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹103 cr, stock is ranked 2,148
High RiskStock is 3.57x as volatile as Nifty
95.650.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹103 cr, stock is ranked 2,148
High RiskStock is 3.57x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
40.38
PB RatioPB Ratio
4.34
Dividend YieldDiv. Yield
Sector PESector PE
12.92
Sector PBSector PB
2.54
Sector Div YldSctr Div Yld
2.39%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Arvee Laboratories provides specialty chemical products. The Company is primarily engaged in manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates

Financial TrendFinancial statements 

201920202021202255.2545.7747.9640.792.262.292.682.57
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Closure of trading window 
Announced OnSep 30, 2022

Arvee Laboratories (India) Limited has informed the Exchange about Closure of trading window from October 01, 2022 and will remain closed till 48 hours after the declaration of results for the quarter ended on 30th September, 2022 | Download

Arvee Laboratories (India) Limited has informed the Exchange about Closure of trading window from October 01, 2022 and will remain closed till 48 hours after the declaration of results for the quarter ended on 30th September, 2022 | Download

Disclosure under SEBI Takeover Regulations 
Announced OnSep 16, 2022

Kavita Shalin Chokshi has Submitted to the Exchange a copy of Disclosure under Regulation 10(6) - Report to Stock Exchanges in respect of any acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 | Download

Kavita Shalin Chokshi has Submitted to the Exchange a copy of Disclosure under Regulation 10(6) - Report to Stock Exchanges in respect of any acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 | Download

Disclosure under SEBI Takeover Regulations 
Announced OnSep 16, 2022

Mitaben Chokshi has Submitted to the Exchange a copy of Disclosure under Regulation 10(6) - Report to Stock Exchanges in respect of any acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 | Download

Mitaben Chokshi has Submitted to the Exchange a copy of Disclosure under Regulation 10(6) - Report to Stock Exchanges in respect of any acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 | Download

See all events